Cancer Immunology Research (CIR)
Journal Descriptions
Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. The journal disseminates knowledge of immunology to the cancer research community, catalyzing cross-disciplinary work that yields a deeper understanding of the host-tumor relationship, more potent cancer treatments, and improved clinical outcomes. Papers are stringently reviewed, and specific topics of interest include endogenous antitumor immunity, tumor-promoting inflammation, cancer antigens, vaccines, antibodies, cellular therapy, cytokines, immune regulation, immune suppression, immunomodulatory effects of cancer treatment, emerging technologies, and clinical investigations. The journal's special features include "Masters of Immunology"—primers by leading immunologists—and "Cancer Immunology at the Crossroads"—perspectives that highlight the intersection of immunology with other areas of cancer research and allied disciplines.
Cancer Immunology Research (CIR) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Immunology, Microbiology, General Medicine, Biochemistry, Molecular Biology, Cancer, Cancer Immunology, Oncology, Immunotherapy, Cellular Therapy, Translational Medicine , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2326-6066, E-ISSN: 2326-6074, Established: 2013, Impact Factor: 10.1
- Provides Crossref DOI
-
Indexed in: Scopus, WoS, PubMed
-
Not indexed in DOAJ, UGC CARE
